TradingKey

關於 Bausch + Lomb Corp 公司

Bausch + Lomb Corporation 是一家眼保健公司。其業務分爲三個部門：視力保健、製藥和外科。視力保健部門包括隱形眼鏡和消費者眼保健業務，包括隱形眼鏡護理產品、非處方眼藥水和眼部維生素。製藥部門包括用於術後治療和多種眼部疾病治療的仿製藥產品，例如青光眼、眼部炎症、眼高壓、乾眼症和視網膜疾病。外科部門包括用於治療白內障、角膜和玻璃體以及視網膜眼部疾病的醫療器械設備、耗材、儀器和技術，其中包括輸送系統、晶狀體乳化設備和其他用於白內障手術的手術器械和設備。其品牌包括 PreserVision、Biotrue、Artelac、Alaway、Mioclear、Ocuvite、ScoutPro、XIIDRA、Vyzulta、Lotemax、Prolensa、Minims、INFUSE 等。

公司簡介

公司代碼BLCO

公司名稱Bausch + Lomb Corp

上市日期May 06, 2022

CEOMr. Brenton L. (Brent) Saunders, J.D.

員工數量13500

證券類型Ordinary Share

年結日May 06

公司地址520 Applewood Crescent

城市VAUGHAN

上市交易所NYSE Consolidated

國家Canada

郵編L4K 4B4

電話19082552864

網址https://ir.bausch.com/

公司代碼BLCO

上市日期May 06, 2022

CEOMr. Brenton L. (Brent) Saunders, J.D.

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Brenton L. (Brent) Saunders, J.D.

Chairman of the Board, Chief Executive Officer

352.13K

+162.32%

Mr. Brett M. Icahn

Independent Director

75.84K

+85.85%

Mr. Luc Bonnefoy

President - Surgical

71.22K

-2.95%

Mr. Russel C. Robertson

Independent Director

64.91K

+53.22%

Dr. Andrew Charles Von Eschenbach, M.D.

Independent Director

62.09K

+55.01%

Dr. Yehia Hashad, M.D.

Executive Vice President - Research & Development, Chief Medical Officer

50.46K

-5.33%

Mr. A. Robert D. Bailey, J.D.

Executive Vice President, Chief Legal Officer

--

Ms. Karen L. Ling

Independent Director

--

Mr. Gary Hu

Independent Director

--

Ms. Sarah B. Kavanagh

Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Brenton L. (Brent) Saunders, J.D.

Chairman of the Board, Chief Executive Officer

352.13K

+162.32%

Mr. Brett M. Icahn

Independent Director

75.84K

+85.85%

Mr. Luc Bonnefoy

President - Surgical

71.22K

-2.95%

Mr. Russel C. Robertson

Independent Director

64.91K

+53.22%

Dr. Andrew Charles Von Eschenbach, M.D.

Independent Director

62.09K

+55.01%

Dr. Yehia Hashad, M.D.

Executive Vice President - Research & Development, Chief Medical Officer

50.46K

-5.33%

收入明細

單位: USD更新時間: 7月6日週日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Devices

448.00M

39.40%

OTC

409.00M

35.97%

Pharmaceuticals

222.00M

19.53%

Branded and other Generics

54.00M

4.75%

Other revenues

4.00M

0.35%

暫無數據

業務

地區

業務USD

名稱

營收

佔比

Devices

448.00M

39.40%

OTC

409.00M

35.97%

Pharmaceuticals

222.00M

19.53%

Branded and other Generics

54.00M

4.75%

Other revenues

4.00M

0.35%

股東統計

更新時間: 7月29日週二

持股股東

股東類型

持股股東

佔比

Bausch Health Companies Inc

87.75%

Deutsche Bank Securities Inc.

0.99%

Icahn Associates Corporation

0.99%

Alberta Investment Management Corporation

0.92%

GoldenTree Asset Management, LP

0.64%

Other

8.72%

持股股東

佔比

Bausch Health Companies Inc

87.75%

Deutsche Bank Securities Inc.

0.99%

Icahn Associates Corporation

0.99%

Alberta Investment Management Corporation

0.92%

GoldenTree Asset Management, LP

0.64%

Other

8.72%

股東類型

持股股東

佔比

Corporation

87.75%

Hedge Fund

4.16%

Investment Advisor/Hedge Fund

2.86%

Research Firm

1.52%

Investment Advisor

1.21%

Sovereign Wealth Fund

0.92%

Individual Investor

0.45%

Pension Fund

0.25%

Family Office

0.18%

Other

0.71%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

263

350.73M

99.13%

-18.03M

2025Q1

273

350.60M

99.12%

-19.40M

2024Q4

262

347.48M

98.58%

-23.77M

2024Q3

257

349.38M

99.14%

-19.72M

2024Q2

260

352.10M

99.92%

-21.43M

2024Q1

247

349.79M

99.91%

-25.18M

2023Q4

237

351.31M

100.35%

-21.66M

2023Q3

219

355.43M

101.52%

-16.80M

2023Q2

207

357.28M

102.06%

-12.23M

2023Q1

194

356.91M

101.97%

-11.11M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

Bausch Health Companies Inc

310.45M

87.77%

--

Mar 24, 2025

Deutsche Bank Securities Inc.

3.50M

0.99%

+3.50M

--

Mar 31, 2025

Icahn Associates Corporation

3.50M

0.99%

--

Mar 31, 2025

Alberta Investment Management Corporation

3.27M

0.92%

+258.00K

+8.58%

Mar 31, 2025

GoldenTree Asset Management, LP

2.25M

0.64%

+516.07K

+29.79%

Mar 31, 2025

Maple Rock Capital Partners, Inc.

1.97M

0.56%

-1.20M

-37.84%

Mar 31, 2025

D. E. Shaw & Co., L.P.

1.88M

0.53%

-6.18K

-0.33%

Mar 31, 2025

Whitebox Advisors, L.L.C.

1.62M

0.46%

+179.78K

+12.46%

Mar 31, 2025

River Road Asset Management, LLC

1.59M

0.45%

+85.05K

+5.64%

Mar 31, 2025

Arrowstreet Capital, Limited Partnership

1.52M

0.43%

+301.42K

+24.74%

Mar 31, 2025

持股ETF

更新時間: 8月2日週六

機構名稱

佔比

Ballast Small/Mid Cap ETF

1.28%

BNY Mellon US Small Cap Core Equity ETF

0.03%

Invesco RAFI Developed Mkts ex-US SM ETF

0.02%

Schwab Fundamental International Small Equity ETF

0.01%

Fidelity Sustainable High Yield ETF

0%

QRAFT AI-Enhanced US Large Cap ETF

0%

DFA Dimensional Intl Sustainability Core 1 ETF

0%

Goldman Sachs MarketBeta US 1000 Equity ETF

0%

Invesco Zacks Mid-Cap ETF

0%

First Trust US Equity Opportunities ETF

0%

Ballast Small/Mid Cap ETF

佔比1.28%

BNY Mellon US Small Cap Core Equity ETF

佔比0.03%

Invesco RAFI Developed Mkts ex-US SM ETF

佔比0.02%

Schwab Fundamental International Small Equity ETF

佔比0.01%

Fidelity Sustainable High Yield ETF

佔比0%

QRAFT AI-Enhanced US Large Cap ETF

佔比0%

DFA Dimensional Intl Sustainability Core 1 ETF

佔比0%

Goldman Sachs MarketBeta US 1000 Equity ETF

佔比0%

Invesco Zacks Mid-Cap ETF

佔比0%

First Trust US Equity Opportunities ETF

佔比0%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Bausch + Lomb Corp

13.735USD

Bausch + Lomb Corp

13.735

概覽

公司

財務